Screener
Fulgent Genetics, Inc. FLGT Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income, net | 10 | 68 |
| Total other income, net | 8,644 | 8,072 |
| Loss before income taxes | (25,978) | (11,723) |
| (Benefit from) provision for income taxes | (704) | 176 |
| Net loss from consolidated operations | (25,274) | (11,899) |
| Net loss attributable to noncontrolling interests | 448 | 369 |
| Net loss attributable to Fulgent | $(24,826) | $(11,530) |
| Net loss per common share attributable to Fulgent |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s income tax?
- Fulgent Genetics, Inc. (FLGT) reported income tax of -$704K in Q1 2026.
- How has Fulgent Genetics, Inc.'s income tax changed year-over-year?
- Fulgent Genetics, Inc.'s income tax decreased by 500.0% year-over-year, from $176K to -$704K.
- What is the long-term trend for Fulgent Genetics, Inc.'s income tax?
- Over 3 years (2021 to 2025), Fulgent Genetics, Inc.'s income tax has grown at a -63.7% compound annual growth rate (CAGR), from $174.8M to -$8.39M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Fulgent Genetics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude